• González Sans has more than 30 years of experience in management and business development in different sectors.
• Atrys, leader in advanced medicine, reaffirms its commitment to preventive health as a key area of its activity.

Atrys, a global healthtech company that provides prevention, diagnosis and precision medical treatment services, leader in telemedicine and oncology treatment, continues to grow and boost its areas of expertise. With the commitment to strengthen its prevention services, Atrys has just announced the appointment of Rosa González Sans as the new managing director of this area. González Sans, who joined the company in April of this year as director of Optimization and Improvement, will now also assume leadership in the development and expansion of the company’s prevention projects, ensuring their growth, sustainability and meeting the objectives that help strengthen Atrys’ position as a leading healthcare services company.

With more than 30 years of experience, Rosa González Sans brings a multidisciplinary profile and leadership in various sectors. Founder and director of Mediaworks, S.A., in 2008 she joined Audax Energía holding positions of responsibility in Finance and Administration; she later became CFO and Business Development Manager in the Italian subsidiary, leading its expansion, and of which she is currently still a director.

In 2019, González Sans participated in the merger process between Audax Energía and Fersa Energía Renovables, which gave rise to Audax Renovables (AR), and of which, since 2021, she has been a member of its Board of Directors.

In 2022, she took over the corporate management of the holding company Excelsior Times S.L., which manages more than 70 companies, and was appointed to the Board of Directors of La Sirena Alimentación Congelada, Agro Water Almonds and Awa Segre, among others. Since 2023, she has also been a trustee of the Fundació Capital Europea del Bàsquet.

In 2021 she was appointed proprietary director of Atrys Health, representing Excelsior Times S.L., until June 2024, when she joins the management team of Atrys.

According to Isabel Lozano, CEO of Atrys, “Rosa’s appointment strengthens the company’s management team, and will contribute to enhance the excellent capabilities of this important division of our group, driving synergies with the diagnostics and oncology divisions. I am confident that her previous experience in high-growth sectors will bring a new vision to further strengthen Atrys’ mission of putting preventive health at the center of our priorities.”

The new managing director, Rosa González Sans, emphasized that “It is an honor to assume the leadership of the Prevention area at Atrys and contribute to the development of one of the most decisive areas for people’s wellbeing. In a world in which prevention is key to improving quality of life and reducing the incidence of disease, my goal is to position prevention as a strategic axis, promoting synergies with the areas of Oncology and Diagnostics to develop innovative solutions that promote health at all levels, from occupational prevention to personalized treatment for our patients”.